298 related articles for article (PubMed ID: 27753082)
21. Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus.
Jayalakshmi S; Patil A; Challa A; Parekh M; Khandelia H; Vooturi S
J Clin Neurosci; 2022 Mar; 97():12-16. PubMed ID: 35030458
[TBL] [Abstract][Full Text] [Related]
22. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
23. Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.
Kortland LM; Knake S; von Podewils F; Rosenow F; Strzelczyk A
Front Neurol; 2017; 8():507. PubMed ID: 29018404
[TBL] [Abstract][Full Text] [Related]
24. Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
Hubert K; Knake S; Bauer S; Voss M; Rosenow F; Strzelczyk A
Epilepsy Behav; 2020 Aug; 109():107139. PubMed ID: 32417381
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
26. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
27. A one-year prospective study of refractory status epilepticus in Modena, Italy.
Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
[TBL] [Abstract][Full Text] [Related]
28. Estimating the cost of admissions related to convulsive status epilepticus in the United States of America.
Sánchez Fernández I; Loddenkemper T
Seizure; 2018 Oct; 61():186-198. PubMed ID: 30179844
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy.
Hsu MH; Kuo HC; Lin JJ; Chou MY; Lin YJ; Hung PL
Biomed J; 2020 Jun; 43(3):277-284. PubMed ID: 32330677
[TBL] [Abstract][Full Text] [Related]
30. Cost of status epilepticus (SE): Effects of delayed treatment and SE duration.
Santamarina E; Parejo B; Abraira L; Gutiérrez-Viedma Á; Alpuente A; Abarrategui B; Toledo M; Mazuela G; Salas-Puig X; Quintana M; García-Morales I
Epilepsy Behav; 2018 Dec; 89():8-14. PubMed ID: 30384104
[TBL] [Abstract][Full Text] [Related]
31. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
32. Cost of status epilepticus: A systematic review.
Kortland LM; Knake S; Rosenow F; Strzelczyk A
Seizure; 2015 Jan; 24():17-20. PubMed ID: 25564314
[TBL] [Abstract][Full Text] [Related]
33. Pediatric refractory and super-refractory status epilepticus.
Vasquez A; Farias-Moeller R; Tatum W
Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
[TBL] [Abstract][Full Text] [Related]
34. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.
Kantanen AM; Kälviäinen R; Parviainen I; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Reinikainen M
Crit Care; 2017 Mar; 21(1):71. PubMed ID: 28330483
[TBL] [Abstract][Full Text] [Related]
35. Mega-dose phenobarbital therapy for super-refractory status epilepticus.
Byun JI; Chu K; Sunwoo JS; Moon J; Kim TJ; Lim JA; Jun JS; Lee HS; Lee WJ; Lee DY; Jeon D; Lee ST; Jung KH; Jung KY; Lee SK
Epileptic Disord; 2015 Dec; 17(4):444-52. PubMed ID: 26575689
[TBL] [Abstract][Full Text] [Related]
36. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
Holtkamp M; Othman J; Buchheim K; Meierkord H
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
[TBL] [Abstract][Full Text] [Related]
37. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study.
Sutter R; Tschudin-Sutter S; Grize L; Fuhr P; Bonten MJ; Widmer AF; Marsch S; Rüegg S
Epilepsia; 2012 Sep; 53(9):1489-97. PubMed ID: 22812603
[TBL] [Abstract][Full Text] [Related]
38. Stiripentol for the treatment of super-refractory status epilepticus.
Strzelczyk A; Kortland LM; Knake S; Rosenow F
Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
[No Abstract] [Full Text] [Related]
40. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
